NANOPEP is an international biotechnological company that develops a wide range of products based on the peptide bioregulation technology.

We are a dedicated team of research scientists and product developers, working with one of the most innovative biotechnologies of the present times, to provide mankind with the most advanced formulas science has to offer.

Our main task is to introduce to the global market consumer-end products based on short peptides that have been obtained as а results of 30-year experimental and clinical studies on their action performed by Professor Khavinson. These short peptides are known as KHAVINSON PEPTIDES®